dijous, 7 d’agost del 2014

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried




Despite the furor on Capitol Hill, lawmakers aren't likely to produce reform that will hinder Medtronic's $43 billion acquisition of Covidien, according to Morgan Stanley analysts.





Analyst report: Dems can't stop Medtronic-Covidien merger



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1u1Vh1s

Cap comentari:

Publica un comentari a l'entrada